Visit CURE at http://curenet.org and BioBus Educational Programs at http://ctbiobus.org

December 4, 2008
 
Will Proposed Federal 'Import' Legislation Hurt Connecticut Bioscience?

The medical research industry in Connecticut is booming.

But is it threatened by proposed new Federal legislation that would require U.S. drug companies to sell to foreign distributors at price-controlled rates?

Paul Pescatello, president and CEO of CURE, writes on the subject in today's New Haven Register.

Go to New Haven Register op-ed.
 
 
Copyright 2008 © Connecticut United for Research Excellence. All rights reserved.
Visit CURE at http://curenet.org and BioBus Educational Programs at http://ctbiobus.org
Click here for Archive of back issues.
Newsletter developed and edited by HarveyMalis Communications LLC, Guilford, Conn.

Managing Your Subscriptions
Click on the "Manage your subscription" link below and then on "Edit Your Profile." To subscribe to a publication, type a "y" in the box to the right of the publication name. To unsubscribe, leave the box blank.